The efficacy of Narrow-Band Ultraviolet-B Therapy on Vitiligo patients | ||||
Minia Journal of Medical Research | ||||
Volume 31, Issue 2, April 2020, Page 277-279 PDF (270.61 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/mjmr.2022.221067 | ||||
View on SCiNiTO | ||||
Authors | ||||
Tag El-Din S. Anabar1; Moataz M. El-Domyati2; Rasha Abdel-Aziz1; Maysa Y. Mohammed.1 | ||||
1Department of Dermatology, Minia University, Minia, Egypt. | ||||
2Department of Dermatology, Minia University, Minia, Egypt | ||||
Abstract | ||||
Background: Vitiligo is an acquired depigmentation disorder of great cosmetic importance, affecting 1% of the general population. Photochemotherapy is the most commonly used treatment modality in vitiligo, but is associated with many short and long-term side-effects. Narrow-band ultraviolet B (NBUVB) therapy has been reported to be an effective and safe therapeutic option in patients with vitiligo. Aim of wok: to explore the efficacy and safety of NB-UVB therapy in vitiligo patients. Patients and methods: twenty patients (eight males and twelve females), aged 15-56 years, with vitiligo, were treated twice weekly with NB-UVB phototherapy for a maximum period of 6 months. Results: At the end of 6 months, fourteen of twenty patients achieved more than 75% repigmentation, whereas 4 patients showed 50% repigmentation and 2 patients showed 25% repigmentation after treatments. Adverse effects were limited and transient. Conclusion: NB-UVB therapy is effective and safe in patients with vitiligo. Long-term follow up is required to establish the stability of repigmentation. Short-term adverse effects of NB-UVB include burning, pruritus and xerosis. | ||||
Keywords | ||||
Vitiligo; Narrow-band ultraviolet; safe therapeutic | ||||
Supplementary Files
|
||||
Statistics Article View: 64 PDF Download: 495 |
||||